Randomized, Comparative, Double-Blind, Placebo-Controlled, Triple-Dummy, Four-Way Cross-Over Study to Investigate Neurocognitive Effects of Brivaracetam in Healthy Subjects.

Trial Profile

Randomized, Comparative, Double-Blind, Placebo-Controlled, Triple-Dummy, Four-Way Cross-Over Study to Investigate Neurocognitive Effects of Brivaracetam in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Brivaracetam (Primary) ; Levetiracetam; Lorazepam
  • Indications Epilepsy; Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
  • Focus Pharmacodynamics
  • Sponsors UCB
  • Most Recent Events

    • 26 Oct 2008 Trial end date changed from 1 Sep 2008 to 1 Oct 2008 as reported by Clinicaltrials.gov.
    • 26 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top